Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine medication that potentiates the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties.
## Primary Indications
* Anxiety disorders
* Insomnia
* Seizure disorders (e.g., status epilepticus)
* Premedication for medical procedures
* Management of alcohol withdrawal symptoms
## Adult Dosing
Dosing varies significantly based on indication and patient factors. Specific titration is often required.
* **Anxiety:** Typically 2-6 mg daily in divided doses. Maximum generally 10 mg/day, but higher doses may be used under close supervision for severe anxiety or agitation.
* **Insomnia:** 2-4 mg at bedtime.
* **Status Epilepticus:** 4 mg IV/IM initially. If seizure persists or recurs after 5-10 minutes, a second dose of 4 mg may be administered. Maximum initial dose is typically considered 8 mg.
* **Premedication:** 2-4 mg orally or IM 2 hours before procedure, or 0.05 mg/kg IM/IV 15-20 minutes prior to procedure (max 4 mg).
## Pediatric Dosing
Dosing in pediatrics is highly variable and often requires careful titration and expert consultation.
* **Anxiety:** No established pediatric dose. Refer to specific clinical guidelines. Typically initiated at low doses (e.g., 0.05 mg/kg/day divided every 8 hours) and titrated cautiously. Max daily dose often considered 0.1 mg/kg/day or 4 mg total, whichever is less.
* **Status Epilepticus:** 0.1 mg/kg IV/IM (max 4 mg per dose) over 2-5 minutes. Repeat dose may be given after 10-15 minutes if necessary. Dosing should be guided by pediatric epilepsy protocols.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; consider reduced doses.
* **Renal Impairment:** Use with caution; consider reduced doses.
* **Elderly:** Initial doses should be reduced by 50% and then carefully titrated due to increased sensitivity and potential for central nervous system (CNS) depression.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency (though may be used cautiously in status epilepticus under respiratory support).
* Severe hepatic insufficiency.
## Adverse Effects
Common: Sedation, drowsiness, dizziness, ataxia, weakness, confusion.
Less common: Hypotension, respiratory depression, paradoxical excitation, amnesia, dependence, withdrawal syndrome.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, sedatives, antipsychotics, antihistamines):** Additive CNS depression, potentially leading to profound sedation, respiratory depression, coma, and death. Use concurrently only when no alternative exists, with extreme caution and reduced doses.
* **CYP450 Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, not CYP450 enzymes, so interactions mediated by these pathways are less common than with other benzodiazepines.
## Monitoring
* Sedation level, respiratory rate, and oxygen saturation, especially with IV administration or in susceptible patients.
* Signs and symptoms of withdrawal upon discontinuation (e.g., anxiety, insomnia, seizures).
* Cognitive function and functional status, particularly in the elderly.
## Clinical Pearls
* Intravenous lorazepam has a slower onset of action compared to diazepam but a longer duration of anticonvulsant activity due to its pharmacokinetic profile.
* Intramuscular absorption can be unpredictable; IV is preferred for rapid onset.
* Abrupt discontinuation can precipitate withdrawal symptoms. Tapering is essential.
* Tolerance to sedative effects can develop with chronic use.
***
*This information is intended for healthcare professionals and does not replace comprehensive prescribing information. Always consult the most current drug monograph and local protocols for complete details before prescribing.*
